This article addresses the critical 'small-n-large-p' problem in neuroimaging classification, where the number of features (p, e.g., voxels) vastly exceeds the number of subjects (n).
Major Depressive Disorder (MDD) exhibits significant clinical and neurobiological heterogeneity, challenging diagnosis and treatment.
This article provides a comprehensive guide to High-Performance Liquid Chromatography with Electrochemical Detection (HPLC-ECD) for the analysis of monoamine neurotransmitters in microdialysates.
This article provides a comprehensive guide for researchers and drug development professionals on the application of High-Performance Liquid Chromatography (HPLC) for analyzing cerebrospinal fluid (CSF) neurotransmitters in Parkinson's disease (PD).
This article provides a comprehensive analysis for researchers, scientists, and drug development professionals on managing hypothalamic-pituitary-adrenal (HPA) axis suppression in corticosteroid treatment.
This meta-analysis systematically examines and compares hypothalamic-pituitary-adrenal (HPA) axis activity in schizophrenia and major depressive disorder (MDD), two major psychiatric conditions with overlapping and distinct pathophysiological features.
This review synthesizes current research comparing Hypothalamic-Pituitary-Adrenal (HPA) axis reactivity between healthy individuals and patients with Major Depressive Disorder (MDD).
This review synthesizes current research on the bidirectional relationship between Hypothalamic-Pituitary-Adrenal (HPA) axis dysfunction and microglial activation, a core mechanism in neuropsychiatric and neurodegenerative disorders.
This article provides a comprehensive review for researchers and drug development professionals on therapeutic approaches for chronic stress-induced Hypothalamic-Pituitary-Adrenal (HPA) axis dysfunction.
This review synthesizes current research on the Hypothalamic-Pituitary-Adrenal (HPA) axis development and its profound sexual dimorphism.